165 related articles for article (PubMed ID: 32918526)
1. Effects of complement gene-set polygenic risk score on brain volume and cortical measures in patients with psychotic disorders and healthy controls.
Holland JF; Cosgrove D; Whitton L; Harold D; Corvin A; Gill M; Mothersill DO; Morris DW; Donohoe G
Am J Med Genet B Neuropsychiatr Genet; 2020 Dec; 183(8):445-453. PubMed ID: 32918526
[TBL] [Abstract][Full Text] [Related]
2. Effects of MiR-137 genetic risk score on brain volume and cortical measures in patients with schizophrenia and controls.
Cosgrove D; Mothersill DO; Whitton L; Harold D; Kelly S; Holleran L; Holland J; Anney R; ; Richards A; Mantripragada K; Owen M; O'Donovan MC; Gill M; Corvin A; Morris DW; Donohoe G
Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):369-376. PubMed ID: 29418072
[TBL] [Abstract][Full Text] [Related]
3. Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.
Nicodemus KK; Hargreaves A; Morris D; Anney R; ; ; Gill M; Corvin A; Donohoe G
JAMA Psychiatry; 2014 Jul; 71(7):778-785. PubMed ID: 24828433
[TBL] [Abstract][Full Text] [Related]
4. Impact of polygenic schizophrenia-related risk and hippocampal volumes on the onset of psychosis.
Harrisberger F; Smieskova R; Vogler C; Egli T; Schmidt A; Lenz C; Simon AE; Riecher-Rössler A; Papassotiropoulos A; Borgwardt S
Transl Psychiatry; 2016 Aug; 6(8):e868. PubMed ID: 27505231
[TBL] [Abstract][Full Text] [Related]
5. Effect of DISC1 SNPs on brain structure in healthy controls and patients with a history of psychosis.
Kähler AK; Rimol LM; Brown AA; Djurovic S; Hartberg CB; Melle I; Dale AM; Andreassen OA; Agartz I
Am J Med Genet B Neuropsychiatr Genet; 2012 Sep; 159B(6):722-30. PubMed ID: 22815203
[TBL] [Abstract][Full Text] [Related]
6. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study.
van Os J; Pries LK; Delespaul P; Kenis G; Luykx JJ; Lin BD; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Cankurtaran EŞ; Kaymak SU; Mihaljevic MM; Petrovic SA; Mirjanic T; Bernardo M; Cabrera B; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Saka MC; ; Arango C; O'Donovan M; Rutten BPF; Guloksuz S
Psychol Med; 2020 Aug; 50(11):1884-1897. PubMed ID: 31414981
[TBL] [Abstract][Full Text] [Related]
7. Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk.
Alnæs D; Kaufmann T; van der Meer D; Córdova-Palomera A; Rokicki J; Moberget T; Bettella F; Agartz I; Barch DM; Bertolino A; Brandt CL; Cervenka S; Djurovic S; Doan NT; Eisenacher S; Fatouros-Bergman H; Flyckt L; Di Giorgio A; Haatveit B; Jönsson EG; Kirsch P; Lund MJ; Meyer-Lindenberg A; Pergola G; Schwarz E; Smeland OB; Quarto T; Zink M; Andreassen OA; Westlye LT;
JAMA Psychiatry; 2019 Jul; 76(7):739-748. PubMed ID: 30969333
[TBL] [Abstract][Full Text] [Related]
8. Beyond C4: Analysis of the complement gene pathway shows enrichment for IQ in patients with psychotic disorders and healthy controls.
Holland JF; Cosgrove D; Whitton L; Harold D; Corvin A; Gill M; Mothersill DO; Morris DW; Donohoe G
Genes Brain Behav; 2019 Nov; 18(8):e12602. PubMed ID: 31385409
[TBL] [Abstract][Full Text] [Related]
9. Impact on the Onset of Psychosis of a Polygenic Schizophrenia-Related Risk Score and Changes in White Matter Volume.
Harrisberger F; Smieskova R; Egli T; Simon AE; Riecher-Rössler A; Fusar-Poli P; Papassotiropoulos A; Borgwardt S
Cell Physiol Biochem; 2018; 48(3):1201-1214. PubMed ID: 30045020
[TBL] [Abstract][Full Text] [Related]
10. Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders.
Calafato MS; Thygesen JH; Ranlund S; Zartaloudi E; Cahn W; Crespo-Facorro B; Díez-Revuelta Á; Di Forti M; ; Hall MH; Iyegbe C; Jablensky A; Kahn R; Kalaydjieva L; Kravariti E; Lin K; McDonald C; McIntosh AM; McQuillin A; Picchioni M; Rujescu D; Shaikh M; Toulopoulou T; Os JV; Vassos E; Walshe M; Powell J; Lewis CM; Murray RM; Bramon E
Br J Psychiatry; 2018 Sep; 213(3):535-541. PubMed ID: 30113282
[TBL] [Abstract][Full Text] [Related]
11. Genetic liability in individuals at ultra-high risk of psychosis: A comparison study of 9 psychiatric traits.
Lim K; Lam M; Huang H; Liu J; Lee J
PLoS One; 2020; 15(12):e0243104. PubMed ID: 33264322
[TBL] [Abstract][Full Text] [Related]
12. MRI Indices of Cortical Development in Young People With Psychotic Experiences: Influence of Genetic Risk and Persistence of Symptoms.
Fonville L; Drakesmith M; Zammit S; Lewis G; Jones DK; David AS
Schizophr Bull; 2019 Jan; 45(1):169-179. PubMed ID: 29385604
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of polygenic risk scores for adults with psychosis.
Landi I; Kaji DA; Cotter L; Van Vleck T; Belbin G; Preuss M; Loos RJF; Kenny E; Glicksberg BS; Beckmann ND; O'Reilly P; Schadt EE; Achtyes ED; Buckley PF; Lehrer D; Malaspina DP; McCarroll SA; Rapaport MH; Fanous AH; Pato MT; Pato CN; Bigdeli TB; Nadkarni GN; Charney AW
Nat Med; 2021 Sep; 27(9):1576-1581. PubMed ID: 34489608
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis.
Derks EM; Vorstman JA; Ripke S; Kahn RS; ; Ophoff RA
PLoS One; 2012; 7(6):e37852. PubMed ID: 22761660
[TBL] [Abstract][Full Text] [Related]
15. A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans.
Rampino A; Taurisano P; Fanelli G; Attrotto M; Torretta S; Antonucci LA; Miccolis G; Pergola G; Ursini G; Maddalena G; Romano R; Masellis R; Di Carlo P; Pignataro P; Blasi G; Bertolino A
Eur Neuropsychopharmacol; 2017 Sep; 27(9):928-939. PubMed ID: 28651857
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia polygenic risk score in psychosis proneness.
Mas-Bermejo P; Papiol S; Via M; Rovira P; Torrecilla P; Kwapil TR; Barrantes-Vidal N; Rosa A
Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1665-1675. PubMed ID: 37301774
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenia risk variants modulate white matter volume across the psychosis spectrum: evidence from two independent cohorts.
Oertel-Knöchel V; Lancaster TM; Knöchel C; Stäblein M; Storchak H; Reinke B; Jurcoane A; Kniep J; Prvulovic D; Mantripragada K; Tansey KE; O'Donovan MC; Owen MJ; Linden DE
Neuroimage Clin; 2015; 7():764-70. PubMed ID: 25844328
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.
Zhang JP; Robinson D; Yu J; Gallego J; Fleischhacker WW; Kahn RS; Crespo-Facorro B; Vazquez-Bourgon J; Kane JM; Malhotra AK; Lencz T
Am J Psychiatry; 2019 Jan; 176(1):21-28. PubMed ID: 30392411
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of genetic variation and psychotic experiences in adolescents.
Zammit S; Hamshere M; Dwyer S; Georgiva L; Timpson N; Moskvina V; Richards A; Evans DM; Lewis G; Jones P; Owen MJ; O'Donovan MC
Schizophr Bull; 2014 Nov; 40(6):1254-62. PubMed ID: 24174267
[TBL] [Abstract][Full Text] [Related]
20. A principal component approach to improve association testing with polygenic risk scores.
Coombes BJ; Ploner A; Bergen SE; Biernacka JM
Genet Epidemiol; 2020 Oct; 44(7):676-686. PubMed ID: 32691445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
